Share-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of stock-based compensation by award type

Stock-based compensation by award type was as follows:

	Three Months Ended March 31,
	2023		2022
Stock options	$	6,894	$	3,323
Restricted stock units	4,838		2,005
Employee stock purchase plan	167		58
Total	$	11,899	$	5,386

Schedule of allocated stock-based compensation expense

The Company allocated stock-based compensation expense in the Company’s Consolidated Statements of Operations and Comprehensive Loss as follows:

	Three Months Ended March 31,
	2023		2022
Research and development	$	5,541	$	2,661
General and administrative	6,358		2,725
Total	$	11,899	$	5,386

Schedule of the stock option activity including weighted average exercise prices, options outstanding and exercisable

A summary of the stock option activity, weighted average exercise prices, options outstanding, exercisable and expected to vest as of March 31, 2023 is as follows (in thousands except weighted average exercise price):

	Number of Shares Underlying Options	Weighted Average Exercise Price
Outstanding, December 31, 2022	12,403	$	14.70
Granted	784	$	22.43
Exercised	(289)	$	7.26
Forfeited	(1)	$	8.64
Outstanding, March 31, 2023	12,897	$	15.34
Vested and exercisable, March 31, 2023	5,668	$	13.66
Vested and expected to vest, March 31, 2023	12,390	$	15.28

Schedule of outstanding shares of RSU awards

The following table presents a summary of the Company's outstanding RSU awards granted as of March 31, 2023 (in thousands except weighted average grant-date fair value):

	Restricted Stock Units	Weighted Average Grant-Date Fair Value
Outstanding, December 31, 2022	3,026	$	15.12
Awarded	76	$	22.71
Vested	(285)	$	14.11
Forfeited	—	$	—
Outstanding, March 31, 2023	2,817	$	15.43
Outstanding, expected to vest	2,624	$	15.43